LB Pharmaceuticals Inc (LBRX)
Nasdaq: LBRX · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2016
Who runs LB Pharmaceuticals Inc
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Turner Heather D
Chief Executive Officer. First filing Sep 2025, latest Sep 12, 2025, 0 filings in all.
Officers reporting now
8
of 16 people with a filing in the last fifteen months
Directors reporting now
8
16 people on the record since 2025
Officerssales are open-market, Oct 13, 2025 to Oct 13, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Miller Joseph M | Chief Financial Officer | Sep 2026 | Oct 13, 2026 | none |
| Kozauer Susan Gani | Chief Medical Officer | Sep 2026 | Oct 13, 2026 | none |
| Pai Panandiker Kaya Kamlesh | Chief Commercial Officer | Nov 2025 | Dec 11, 2025 | none |
| Panoff Marc L | Senior Vice President, Finance | Sep 2025 | Sep 29, 2025 | none |
| Turner Heather D | Chief Executive Officer | Sep 2025 | Sep 12, 2025 | none |
| Eramo Anna | Chief Medical Officer | Sep 2025 | Sep 12, 2025 | none |
| Soffer Gad | Chief Business Officer | Sep 2025 | Sep 12, 2025 | none |
| Silva Richard Anthony | SVP, Technical Operations | Sep 2025 | Sep 12, 2025 | none |
Directorssales are open-market, Oct 13, 2025 to Oct 13, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Garland J. Scott | director | Sep 2025 | Jun 5, 2026 | none |
| Hemrajani Rekha | director | Sep 2025 | Jun 5, 2026 | none |
| Kane William P Jr | director | Sep 2025 | Jun 5, 2026 | none |
| Lenz Robert A. | director | Mar 2026 | Jun 5, 2026 | none |
| Luse Rebecca | director | Sep 2025 | Jun 5, 2026 | none |
| Nussbaum Ran | director | Sep 2025 | Jun 5, 2026 | none |
| Ruffolo Robert R | director | Sep 2025 | Jun 5, 2026 | none |
| Prensky Zachary | director | Sep 2025 | Sep 12, 2025 | none |
Owners of more than 10% of a classsales are open-market, Oct 13, 2025 to Oct 13, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. | 10% owner | Sep 2025 | Aug 3, 2026 | none |
| Deep Track Capital, LP | 10% owner | Sep 2025 | Aug 3, 2026 | none |
| Kroin David | 10% owner | Sep 2025 | Aug 3, 2026 | none |
| Deep Track Special Opportunities Fund, LP | 10% owner | Sep 2025 | Feb 10, 2026 | none |
| Belldegrun Arie | 10% owner | Sep 2025 | Sep 16, 2025 | none |
| Pontifax Management 4 G.P. (2015) Ltd. | 10% owner | Sep 2025 | Sep 16, 2025 | none |
| Vida Ventures Gp III, L.L.C. | 10% owner | Sep 2025 | Sep 16, 2025 | none |
| Vida Ventures III-A, L.P. | 10% owner | Sep 2025 | Sep 16, 2025 | none |
| Vida Ventures III, L.P. | 10% owner | Sep 2025 | Sep 16, 2025 | none |
| Vida Ventures Management Co. LLC | 10% owner | Sep 2025 | Sep 16, 2025 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.